Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.
Numerous members of the nuclear hormone receptor (NR) superfamily have been demonstrated to regulate metabolic function in a cell- and tissue-specific manner. This review brings together recent studies that have associated members of the NR superfamily, the orphan NR4A subgroup, with the regulation of metabolic function and disease. The orphan NR4A subgroup includes Nur77 (NR4A1), Nurr1 (NR4A2), and Nor-1 (NR4A3). Expression of these receptors is induced in multiple tissues by a diverse range of stimuli, including stimuli associated with metabolic function, such as: β-adrenoceptor agonists, cold, fatty acids, glucose, insulin, cholesterol, and thiazolidinediones. In vitro and in vivo gain- and loss-of-function studies in major metabolic tissues (including skeletal muscle, adipose, and liver cells and tissues) have associated the NR4A subgroup with specific aspects of lipid, carbohydrate, and energy homeostasis. Most excitingly, although these orphan receptors do not have known endogenous ligands, several small molecule agonists have recently been identified. The preliminary studies reviewed in this manuscript suggest that therapeutic exploitation of the NR4A subgroup may show utility against dyslipidemia, obesity, diabetes, and cardiovascular disease.
Pearen
Michael A
MA
Institute for Molecular Bioscience, The University of Queensland, Queensland, Australia. m.pearen@uq.edu.au
Muscat
George E O
GE
D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004734:Energy Metabolism; D006801:Humans; D008659:Metabolic Diseases / Q000378:metabolism* / Q000503:physiopathology; D015394:Molecular Structure; D018482:Muscle, Skeletal / Q000378:metabolism; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1 / Q000819:agonists / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D014018:Tissue Distribution
D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP
Mol Cell Biol. 1999 Nov;19(11):7549-57
10523643
J Biol Chem. 2003 Jul 4;278(27):24776-90
12709428
J Mol Endocrinol. 2005 Jun;34(3):835-48
15956351
J Neurochem. 2008 Jul;106(2):875-88
18466322
Hum Mol Genet. 1995 Dec;4(12):2219-26
8634690
J Biol Chem. 2008 May 2;283(18):12564-70
18292087
DNA Cell Biol. 2000 Feb;19(2):121-30
10701778
J Biol Chem. 2005 Aug 12;280(32):29256-62
15964844
Mol Endocrinol. 1992 Dec;6(12):2129-35
1491694
Mech Ageing Dev. 2009 Apr;130(4):240-7
19150624
J Biol Chem. 2005 May 13;280(19):19250-8
15716272
Arthritis Rheum. 2001 Apr;44(4):782-93
11315917
J Invest Dermatol. 2006 Nov;126(11):2490-506
16888633
Science. 1991 May 31;252(5010):1296-300
1925541
Immunity. 1995 Sep;3(3):273-82
7552993
Am J Physiol Endocrinol Metab. 2003 Oct;285(4):E775-82
12824081
Mol Cell Biol. 1993 Oct;13(10):6124-36
8413214
Science. 1995 Jul 28;269(5223):532-5
7624775
Science. 2002 Aug 2;297(5582):843-5
12161655
J Neurosci Res. 1989 Sep;24(1):107-14
2572704
FASEB J. 2005 Sep;19(11):1498-500
15985525
Neuron. 1988 May;1(3):183-8
3272167
Circ Res. 2003 Jan 10;92(1):96-103
12522126
Mol Cell Biol. 1993 Sep;13(9):5794-804
8395013
J Biol Chem. 2005 Jul 1;280(26):24903-14
15871945
Mol Cancer Ther. 2004 Mar;3(3):247-60
15026545
Biochim Biophys Acta. 1995 Apr 6;1266(1):91-100
7718627
J Mol Endocrinol. 2007 Dec;39(6):365-74
18055484
Mol Cell Biochem. 1998 Apr;181(1-2):191-5
9562255
Endocrinology. 2001 Dec;142(12):5116-23
11713204
J Lipid Res. 1993 Jul;34(7):1057-91
8371057
Endocrine. 2007 Feb;31(1):5-17
17709892
Annu Rev Physiol. 1983;45:139-53
6342511
Atherosclerosis. 2006 Feb;184(2):276-82
15949808
Mol Hum Reprod. 2005 Feb;11(2):79-85
15615861
Nucl Recept Signal. 2006;4:e002
16604165
Cancer Res. 2007 Jan 15;67(2):674-83
17234778
J Biol Chem. 2004 Dec 17;279(51):53338-45
15456745
Diabetes. 1999 Oct;48(10):2007-14
10512366
Mol Cell Biol. 1995 Aug;15(8):4331-16
7623827
Int J Oncol. 1998 Jun;12(6):1237-43
9592180
J Neurochem. 1999 Nov;73(5):2218-21
10537083
Science. 1997 Apr 11;276(5310):248-50
9092472
Gene. 1998 Apr 28;211(1):79-85
9573341
Circulation. 2007 Jan 30;115(4):493-500
17242285
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1959-65
7811288
Diabetes. 2009 Dec;58(12):2788-96
19741162
Neuroreport. 2004 Jan 19;15(1):99-102
15106839
Proc Natl Acad Sci U S A. 1987 Mar;84(5):1182-6
3469660
Mol Cell Biol. 1994 May;14(5):3469-83
8164692
Mol Endocrinol. 2006 Apr;20(4):786-94
16339277
Mol Endocrinol. 2008 Dec;22(12):2596-608
18945812
Cell. 2006 Aug 25;126(4):789-99
16923397
Int J Obes (Lond). 2008 Feb;32(2):388-92
18071346
J Biol Chem. 2005 Apr 1;280(13):12573-84
15640143
Mol Endocrinol. 2004 Sep;18(9):2123-31
15243132
J Biol Chem. 2007 Oct 26;282(43):31525-33
17785466
Nat Med. 2006 Sep;12(9):1048-55
16906154
Biochem Biophys Res Commun. 2008 Feb 22;366(4):910-6
18086558
Mol Endocrinol. 2005 Oct;19(10):2437-50
16051663
Nature. 1994 Jan 20;367(6460):277-81
8121493
Nat Chem Biol. 2008 Sep;4(9):548-56
18690216
Endocrinology. 2002 Jun;143(6):2208-15
12021184
C R Biol. 2006 Aug;329(8):623-38; discussion 653-5
16860280
Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):697-702
14962944
Biochem Biophys Res Commun. 1998 Oct 9;251(1):334-8
9790956
Biochem Biophys Res Commun. 2009 Aug 21;386(2):311-5
19523439
Endocrinology. 2000 Jul;141(7):2392-400
10875239
Genes Dev. 1995 Apr 1;9(7):769-82
7705655
Cell. 1994 Dec 30;79(7):1147-56
8001151
Carcinogenesis. 2004 Aug;25(8):1467-75
15016657
J Biochem. 2007 Feb;141(2):181-92
17167038
Mol Cell Endocrinol. 2009 Oct 15;309(1-2):101-8
19465082
J Neurosci. 1993 Dec;13(12):5126-38
8254363
Mol Endocrinol. 2004 Feb;18(2):279-90
14645496
J Biol Chem. 2007 Mar 30;282(13):9492-9504
17283078
Mol Cell Biol. 1993 Feb;13(2):861-8
8380897
Nat Med. 1999 Sep;5(9):1066-70
10470087
Endocrinology. 2009 Nov;150(11):4883-91
19819977
Biochem Biophys Res Commun. 2003 Jun 20;306(1):144-50
12788080
J Thromb Haemost. 2007 Aug;5(8):1766-73
17596136
Curr Opin Lipidol. 2007 Oct;18(5):515-20
17885421
Mol Endocrinol. 2007 Sep;21(9):2152-63
17550977
Circulation. 2002 Sep 17;106(12):1530-5
12234960
Endocrinology. 2005 Jan;146(1):237-46
15486232
Physiol Genomics. 2005 Dec 14;24(1):37-44
16219868
Mol Cell Biol. 1997 Oct;17(10):5946-51
9315652
J Biol Chem. 1997 Dec 12;272(50):31278-84
9395454
EMBO J. 1985 Dec 1;4(12):3145-51
3841511
Am J Physiol. 1992 Nov;263(5 Pt 1):E850-5
1443116
Cardiovasc Res. 2005 Feb 15;65(3):609-18
15664387
Am J Physiol. 1998 Dec;275(6):E909-16
9843731
Biol Pharm Bull. 2005 Sep;28(9):1603-7
16141523
Mol Endocrinol. 2008 May;22(5):1057-64
18238829
Biochim Biophys Acta. 2009 Aug;1792(8):777-82
19447175
Am J Physiol. 1994 Aug;267(2 Pt 1):E306-15
7915493
Mol Cell Biol. 1990 Dec;10(12):6454-9
2247065
Biochem J. 1995 Jun 15;308 ( Pt 3):785-9
8948433
J Biol Chem. 2002 Sep 6;277(36):33001-11
12082103
BMC Med Genet. 2009 Aug 14;10:77
19682370
Proc Natl Acad Sci U S A. 1988 Nov;85(22):8444-8
3186734
Mol Cell Biol. 1991 Jun;11(6):3239-46
1645447
Oncogene. 1996 Jan 18;12(2):229-35
8570200
Mol Cell Endocrinol. 1995 Dec 29;115(2):227-30
8824899
Endocrinology. 2008 Jun;149(6):2853-65
18325999
Bioorg Med Chem Lett. 2007 Jan 1;17(1):193-6
17035009
Arterioscler Thromb Vasc Biol. 2006 Oct;26(10):2288-94
16873729
Endocrinology. 2006 Nov;147(11):5217-27
16901967
ChemMedChem. 2006 Sep;1(9):955-8
16952138
Cancer Lett. 1995 Sep 4;96(1):117-22
7553599
J Biol Chem. 2003 Jul 4;278(27):24791-9
12709433
Leukemia. 1997 Sep;11(9):1453-8
9305597
Brain Res Mol Brain Res. 1991 Aug;11(1):43-6
1662744
Mol Endocrinol. 1996 Dec;10(12):1656-66
8961274
Biochim Biophys Acta. 1996 Sep 11;1308(3):205-14
8809112
Clin Sci (Lond). 1986 May;70(5):435-41
2870833
Behav Brain Res. 2002 Oct 17;136(1):267-75
12385813
FASEB J. 1998 Sep;12(12):1173-82
9737720
Mol Endocrinol. 1995 Dec;9(12):1692-700
8614405
Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1535-40
12842839
Nature. 2003 May 29;423(6939):555-60
12774125
Nature. 1994 Jan 20;367(6460):281-4
8121494